CronosvsCorteva

CRON and CTVA stock compared: price, dividend, valuation and results, from SEC filings.

Over the last year, with dividends, CRON moved +33.1% and CTVA -4.5%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CRON$1.3B

    CTVA–

  • Revenue, 12 months

    CRON$206M

    CTVA$17.7B

    CTVA is 86 times CRON

  • Net income, 12 months

    CRON$58M

    CTVA$759M

    CTVA is 13 times CRON

  • Operating margin

    CRON3.4%

    CTVA–

  • ROIC

    CRON0.5%

    CTVA3.0%

    2.5 points apart

  • P/E

    CRON22.2

    CTVA–

  • Dividend yield

    CRON0.0%

    CTVA0.0%

    About the same

  • 5-year return

    CRON-46.0%

    CTVA+35.7%

    81.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CRON-46.0%

CTVA+35.7%

5010015020020222023202420252026
Returns by period
PeriodCRONWith dividendsCTVAWith dividends
1 year since November 12, 2025+33.1%Price +33.1%-4.5%Price -5.4%
3 years since November 13, 2023+68.2%+18.9% a yearPrice +68.2%+43.2%+12.7% a yearPrice +38.7%
5 years since November 12, 2021-46.0%-11.6% a yearPrice -46.0%+35.7%+6.3% a yearPrice +29.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CRONCronosCTVACorteva

Valuation

CRONCTVA
Valuation
Price$3.38$9.43
Market value$1.3B–
Enterprise value (EV)$540M–
P/E22.2–
P/E, 5-year median–41.9
P/B1.2–
EV/EBIT76.1–
Free cash flow yield5.1%–

Results and growth

CRONCTVA
Results and growth
Revenue, 12 months$206M$17.7B
Net income, 12 months$58M$759M
Free cash flow, 12 months$65M-$149M
Earnings per share, 12 months$0.17$1.14
Revenue growth, year on year24.6%2.9%
Revenue growth a year, past+25.7%over 5 years+4.1%over 5 years
EPS growth a year, past–+12.0%over 5 years

Margins and returns on capital

CRONCTVA
Margins and returns on capital
Gross margin46.6%49.7%
Operating margin3.4%–
Net margin28.0%4.3%
ROIC0.5%3.0%
ROE5.4%3.1%

Balance sheet

CRONCTVA
Balance sheet
Cash$741M$3.9B
Total debt$1.2M$7.4B
Net debt / EBITDA-34.71.4
Interest cover–6.7×

Dividends and buybacks

CRONCTVA
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months–$0.72
Dividend growth a year, past–+6.1%over 5 years
Buyback yield0.8%–
Shareholder yield0.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CRON or CTVA

Didn't find what you were looking for?

Ask us
How did CRON and CTVA stock do over the last 5 years?

Since November 12, 2021, CRON's price moved -46.0% and CTVA's +29.0%. With dividends: CRON -46.0% (-11.6% a year), CTVA +35.7% (+6.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, CRON or CTVA?

Neither paid a dividend over the last twelve months: Cronos and Corteva return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Cronos or Corteva?

Over the last twelve months, the net margin was 28.0% for Cronos and 4.3% for Corteva, and the operating margin 3.4% and –. Revenue was $206M and $17.7B.

Which is the better investment, Cronos or Corteva?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.